Paul Howley | Chief Executive Officer
Sementis | Australia

Paul Howley, Chief Executive Officer, Sementis

Dr Paul Howley has experience and expertise in vaccine design and development of vaccines from concept to clinical trials. Scientific background has been in the field of molecular virology, specialising in viral vectors systems and vaccinology. Inventor of the company's SCV platform vaccine delivery technology and of a number of vaccines in development. Directs and manages the vaccine development programs for Sementis, utilising extensive knowledge, experience and networks in the areas of antigen design and discovery, proof of concept studies in animal models, GLP preclinical and toxicology studies, process development and cGMP manufacturing, regulatory affairs and cGCP first in man studies concerning live viral vectored vaccines.

Appearances:



Phar-East Day Two @ 11:40

Overcoming the complexities of conjugate vaccine production

  •     Exploring existing challenges in managing the complexities in conjugate vaccine production 
  •     Discovering alternative expression systems for vaccine cultivation
  •     Case study: Using in-vivo recombinant technology to produce conjugate vaccines

Phar-East Day Two @ 15:45

Biotech Showcase

back to speakers